NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test guides precision strikes against lingering lung cancer
Disease control CompletedThis study tested a new strategy for controlling advanced lung cancer that has spread. It aimed to see if using a sensitive blood test to detect tiny amounts of leftover cancer could guide doctors to use targeted radiation or surgery on the remaining tumors. The goal was to see i…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug duo tested to fight Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether adding a new drug called bemcentinib (BGB324) to an existing immunotherapy (pembrolizumab) could help control advanced lung cancer that had worsened after prior treatment. It involved 99 adults with a specific type of lung cancer (adenocarcinoma) whose d…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New scan could tell doctors if cancer treatment will work
Knowledge-focused CompletedThis study tested whether a special type of PET scan could predict which patients with advanced non-small cell lung cancer (NSCLC) would respond well to immunotherapy drugs like nivolumab. Eighty patients received the scan before starting treatment to see if it could accurately f…
Matched conditions: NSCLC STAGE IV
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC